Group

Prostate cancer

(N = 75)

Mean ± SD (range)

Prostatic hyperplasia

(N = 60)

Mean ± SD (range)

Apparently healthy

(N = 45)

Mean ± SD (range)

Factors

PSA ng/ml

67.52 ± 123.66

(4.62 - 1030)

15.41 ± 20.68

(2.45 - 92.78)

1.93 ± 1.04

(0.33 - 3.80)

fPSA ng/ml

8.04 ± 15.04

(0.48 - 122)

4.15 ± 6.77

(0.44 - 35.12)

0.48 ± 0.29

(0.10 - 1.22)

KLK-2 ng/ml

0.41 ± 0.54

(0.03 - 2.33)

0.22 ± 0.24

(0.02 - 0.74)

0.15 ± 0.13

(0.02 - 0.51)

fPSA/PSA (%)

12.57 ± 7.31

(5.91 - 67.13)

23.66 ± 7.50

(8.39 - 45.36)

25.83 ± 7.75

(13.61 - 43.08)

KLK-2/PSA (%)

0.661 ± 0.49

(0.05 - 1.94)

1.52 ± 1.01

(0.39 - 4.62)

7.61 ± 4.13

(2.91 - 22.12)

KLK-2/fPSA (%)

6.03 ± 4.17

(0.272 - 19.95)

7.47 ± 6.70

(1.50 - 39.57)

30.33 ± 13.8

(8.15 - 58.38)